Future advances in therapeutics demand the development of dynamic and intelligent living
materials. The past static monofunctional materials shall be unable to meet the requirements …

Inflammatory bowel disease (IBD) is a recurring chronic inflammatory disease. Current
treatment strategies are aimed at alleviating clinical symptoms and are associated with …

Abstract Pristine CdO and chromium (Cr)-cobalt (Co) co-doped CdO nanowires via a facile
co-precipitation protocol were synthesized and characterized with different analytical …

Background & Aims Neuroinflammation in the gut is associated with many gastrointestinal
(GI) diseases, including inflammatory bowel disease. In the brain, neuroinflammatory …

Previously, the presence of a blood-myenteric plexus barrier and its disruption was reported
in experimentally induced colitis via a macrophage-dependent process. The aim of this …

We present an overview of recent experimental and computational advances in technology
used to characterize the microbiome, with a focus on how these developments improve our …

Bacteria-based therapies are powerful strategies for cancer therapy, yet their clinical
application is limited by a lack of tunable genetic switches to safely regulate the local …

Gut microbiota has been shown to systemically shape the immunological landscape,
modulate homeostasis and play a role in both health and disease. Dysbiosis of gut …

With the rising morbidity of inflammatory bowel disease (IBD) year by year, conventional
therapeutic drugs with systemic side effects are no longer able to meet the requirements of …

The emergence of antibiotic‐resistant strains, the decreased effectiveness of conventional
therapies, and the side effects have led researchers to seek a safer, more cost‐effective …